The MDM2 gene amplification database
J Momand, D Jung, S Wilczynski… - Nucleic acids …, 1998 - academic.oup.com
The p53 tumor suppressor gene is inactivated in human tumors by several distinct
mechanisms. The best characterized inactivation mechanisms are:(i) gene mutation;(ii) p53 …
mechanisms. The best characterized inactivation mechanisms are:(i) gene mutation;(ii) p53 …
The role of MDM2 amplification and overexpression in tumorigenesis
JD Oliner, AY Saiki… - Cold Spring …, 2016 - perspectivesinmedicine.cshlp.org
Mouse double minute 2 (MDM2) is a critical negative regulator of the tumor suppressor p53,
playing a key role in controlling its transcriptional activity, protein stability, and nuclear …
playing a key role in controlling its transcriptional activity, protein stability, and nuclear …
World Health Organization classification of tumours: Pathology & genetics of tumours of the urinary system and male genital organs
TY Chan - Urology, 2005 - goldjournal.net
This 2004 volume in the World Health Organization series on histologic and genetic typing
of human tumors covers tumors of the kidney, urinary system, prostate, testis and …
of human tumors covers tumors of the kidney, urinary system, prostate, testis and …
MDMX: a novel p53‐binding protein with some functional properties of MDM2.
A Shvarts, WT Steegenga, N Riteco, T Van Laar… - The EMBO …, 1996 - embopress.org
Here we report the isolation of a cDNA encoding a new p53‐associating protein. This new
protein has been called MDMX on the basis of its structural similarity to MDM2, which is …
protein has been called MDMX on the basis of its structural similarity to MDM2, which is …
[HTML][HTML] Molecular pathogenesis of oral squamous carcinoma
HK Williams - Molecular Pathology, 2000 - ncbi.nlm.nih.gov
Oral squamous carcinogenesis is a multistep process in which multiple genetic events occur
that alter the normal functions of oncogenes and tumour suppressor genes. This can result …
that alter the normal functions of oncogenes and tumour suppressor genes. This can result …
Inactivation of p53 and Pten promotes invasive bladder cancer
AM Puzio-Kuter, M Castillo-Martin… - Genes & …, 2009 - genesdev.cshlp.org
Although bladder cancer represents a serious health problem worldwide, relevant mouse
models for investigating disease progression or therapeutic targets have been lacking. We …
models for investigating disease progression or therapeutic targets have been lacking. We …
Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese?
MA Knowles - Carcinogenesis, 2006 - academic.oup.com
Cancer of the bladder shows divergent clinical behaviour following diagnosis and it has
been proposed that two major groups of tumours exist that develop via different molecular …
been proposed that two major groups of tumours exist that develop via different molecular …
Whole-genome sequencing of bladder cancers reveals somatic CDKN1A mutations and clinicopathological associations with mutation burden
Bladder cancers are a leading cause of death from malignancy. Molecular markers might
predict disease progression and behaviour more accurately than the available prognostic …
predict disease progression and behaviour more accurately than the available prognostic …
Prognostic markers in bladder cancer: a contemporary review of the literature
JP Stein, GD Grossfeld, DA Ginsberg, D Esrig… - The Journal of …, 1998 - auajournals.org
Purpose: We provide a contemporary review of bladder tumor markers and summarize their
role as prognostic indicators. Materials and Methods: A comprehensive review of the …
role as prognostic indicators. Materials and Methods: A comprehensive review of the …
Proteasome system of protein degradation and processing
AV Sorokin, ER Kim, LP Ovchinnikov - Biochemistry (Moscow), 2009 - Springer
In eukaryotic cells, degradation of most intracellular proteins is realized by proteasomes.
The substrates for proteolysis are selected by the fact that the gate to the proteolytic chamber …
The substrates for proteolysis are selected by the fact that the gate to the proteolytic chamber …